New immunotherapy drug effective for melanoma, other cancers
Insight into early stages of bowel cancer could provide new treatments
3 June 2021What guides habitual seeking behavior—like addiction—explained
3 June 2021New immunotherapy drug effective for melanoma, other cancers
A new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients, a breakthrough that could extend to the treatment of other cancers. Relatlimab is the first immunotherapy treatment to target LAG-3, a protein in immune cells which reinvigorates and enhances the tumor fighting response.
